Advertisement
Screener

FRANKLIN COVEY CO. (FC) Increase (Decrease) in Deferred Revenue

2.8 / 5 stars · 68/120 Roast Me

FRANKLIN COVEY CO. Increase (Decrease) in Deferred Revenue

FRANKLIN COVEY CO. (FC) reported Increase (Decrease) in Deferred Revenue of $2.81 million for the 12-month period ending 2020-08-31, per its 10-K filed 2020-11-16.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2020-11-16

  • FRANKLIN COVEY CO. increase (decrease) in deferred revenue for the quarter ending 2018-08-31 was $13.83M, a 15.80% increase year-over-year.
  • FRANKLIN COVEY CO. increase (decrease) in deferred revenue for the quarter ending 2018-05-31 was $3.17M, a 54.21% decline year-over-year.
  • FRANKLIN COVEY CO. increase (decrease) in deferred revenue for the quarter ending 2018-02-28 was $182.00K, a 78.07% decline year-over-year.
  • FRANKLIN COVEY CO. increase (decrease) in deferred revenue for the quarter ending 2017-11-30 was -$5.57M.
  • FRANKLIN COVEY CO. increase (decrease) in deferred revenue for fiscal 2020 was $2.81M, a 68.21% decline from fiscal 2019.
  • FRANKLIN COVEY CO. increase (decrease) in deferred revenue for fiscal 2019 was $8.83M, a 23.98% decline from fiscal 2018.
  • FRANKLIN COVEY CO. increase (decrease) in deferred revenue for fiscal 2018 was $11.61M, a 39.33% decline from fiscal 2017.
  • FRANKLIN COVEY CO. increase (decrease) in deferred revenue for fiscal 2017 was $19.14M, a 135.97% increase from fiscal 2016.
Period endIncrease (Decrease) in Deferred Revenue 3 monthIncrease (Decrease) in Deferred Revenue 6 monthIncrease (Decrease) in Deferred Revenue 9 monthIncrease (Decrease) in Deferred Revenue 12 month
2020-08-31$2.81M
10-K · filed 2020-11-16
2019-08-31$8.83M
10-K · filed 2020-11-16
2018-08-31$13.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-16
$17.00M
derived: sum of 2 quarters · filed 2020-11-16
$17.18M
derived: sum of 3 quarters · filed 2020-11-16
$11.61M
10-K · filed 2020-11-16
2018-05-31$3.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-10
$3.35M
derived: sum of 2 quarters · filed 2018-07-10
-$2.22M
10-Q · filed 2018-07-10
$9.73M
derived: sum of 4 quarters · filed 2019-11-14
2018-02-28$182.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-09
-$5.39M
10-Q · filed 2018-04-09
$6.56M
derived: sum of 3 quarters · filed 2019-11-14
$13.48M
derived: sum of 4 quarters · filed 2019-11-14
2017-11-30-$5.57M
10-Q · filed 2018-01-09
$6.38M
derived: sum of 2 quarters · filed 2019-11-14
$13.29M
derived: sum of 3 quarters · filed 2019-11-14
$14.13M
derived: sum of 4 quarters · filed 2019-11-14
2017-08-31$11.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14
$18.86M
derived: sum of 2 quarters · filed 2019-11-14
$19.70M
derived: sum of 3 quarters · filed 2019-11-14
$19.14M
10-K · filed 2019-11-14
2017-05-31$6.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-10
$7.75M
derived: sum of 2 quarters · filed 2018-07-10
$7.20M
10-Q · filed 2018-07-10
$14.94M
derived: sum of 4 quarters · filed 2018-11-14
2017-02-28$830.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-09
$277.00K
10-Q · filed 2018-04-09
$8.02M
derived: sum of 3 quarters · filed 2018-11-14
$10.57M
derived: sum of 4 quarters · filed 2018-11-14
2016-11-26-$553.00K
10-Q · filed 2018-01-09
$7.19M
derived: sum of 2 quarters · filed 2018-11-14
$9.74M
derived: sum of 3 quarters · filed 2018-11-14
$10.16M
derived: sum of 4 quarters · filed 2018-11-14
2016-08-31$7.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14
$10.29M
derived: sum of 2 quarters · filed 2018-11-14
$10.71M
derived: sum of 3 quarters · filed 2018-11-14
$8.11M
10-K · filed 2018-11-14
2016-05-28$2.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-07-10
$2.97M
derived: sum of 2 quarters · filed 2017-07-10
$368.00K
10-Q · filed 2017-07-10
2016-02-27$417.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-04-07
-$2.18M
10-Q · filed 2017-04-07
2015-11-28-$2.60M
10-Q · filed 2017-01-05
2015-08-31$2.48M
10-K · filed 2017-11-14
2014-08-31$3.29M
10-K · filed 2016-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Evolent Health, Inc. (EVH)United States$0.397B-1.21
GARTNER INC (IT)United States$11.326B11.20